Oldest pages

From NeuroRehab.wiki

Showing below up to 50 results in range #1,301 to #1,350.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. DIABETES INSIPIDUS-INVESTIGATIONS‏‎ (11:07, 20 March 2023)
  2. DIABETES MELLITUS-TYPE 2, MANAGEMENT‏‎ (11:07, 20 March 2023)
  3. PITUITARY-ACTH‏‎ (11:07, 20 March 2023)
  4. OSTEOPOROSIS-RISK FACTORS‏‎ (11:07, 20 March 2023)
  5. DIABETES MELLITUS-GLITAZONES‏‎ (11:07, 20 March 2023)
  6. PITUITARY-METASTASIS‏‎ (11:07, 20 March 2023)
  7. OSTEOPOROSIS-DISH‏‎ (11:07, 20 March 2023)
  8. HYPERTHYROIDISM-DIFFERENTIALS‏‎ (11:07, 20 March 2023)
  9. THYROID NODULE-RISK FACTORS‏‎ (11:07, 20 March 2023)
  10. DIABETES MELLITUS-PRE DIABETES INX‏‎ (11:07, 20 March 2023)
  11. HORMONES-ENDOCRINE GENERALITIES‏‎ (11:07, 20 March 2023)
  12. OSTEOPOROSIS-MANAGEMENT (ESTROGEN SIDE EFFECTS)‏‎ (11:07, 20 March 2023)
  13. DIABETES INSIPIDUS-MANAGEMENT‏‎ (11:07, 20 March 2023)
  14. PITUITARY-ADH‏‎ (11:07, 20 March 2023)
  15. THYROID-FUNCTION TEST‏‎ (11:07, 20 March 2023)
  16. OSTEOPOROSIS-SCREENING‏‎ (11:07, 20 March 2023)
  17. ADRENAL GLAND-MEDULLA‏‎ (11:07, 20 March 2023)
  18. DIABETES MELLITUS-GLP 1 AGONISTS‏‎ (11:07, 20 March 2023)
  19. HYPERTHYROIDISM-INVESTIGATION‏‎ (11:07, 20 March 2023)
  20. DIABETES MELLITUS-REMISSION‏‎ (11:07, 20 March 2023)
  21. PHAEOCHROMOCYTOMA‏‎ (11:07, 20 March 2023)
  22. HORMONES-GLUCOCORTICOIDS‏‎ (11:07, 20 March 2023)
  23. OSTEOPOROSIS-MANAGEMENT (ROMOSOZUMAB)‏‎ (11:07, 20 March 2023)
  24. PITUITARY-ANTERIOR‏‎ (11:07, 20 March 2023)
  25. HYPERPARATHYROIDISM-SECONDARY OR TERTIARY‏‎ (11:07, 20 March 2023)
  26. OSTEOPOROSIS-VITAMIN D‏‎ (11:07, 20 March 2023)
  27. ADRENAL GLAND-MINERALOCORTICOIDS‏‎ (11:07, 20 March 2023)
  28. DIABETES MELLITUS-HHNK‏‎ (11:07, 20 March 2023)
  29. PITUITARY-PROLACTIN‏‎ (11:07, 20 March 2023)
  30. OSTEOPOROSIS-FRACTURE RISK CALCULATORS‏‎ (11:07, 20 March 2023)
  31. THYROID STORM‏‎ (11:07, 20 March 2023)
  32. MYXEDEMA COMA‏‎ (11:07, 20 March 2023)
  33. DIABETES MELLITUS-SECONDARY PREVENTION OF CV DISEASES‏‎ (11:07, 20 March 2023)
  34. PHAEOCHROMOCYTOMA-COMPLICATIONS‏‎ (11:07, 20 March 2023)
  35. HORMONES-NEGATIVE AND POSITIVE FEEDBACK‏‎ (11:07, 20 March 2023)
  36. OSTEOPOROSIS-MANAGEMENT (SERM)‏‎ (11:07, 20 March 2023)
  37. FAMILIAL HYPOCALCEURIC HYPERCALCEMIA‏‎ (11:07, 20 March 2023)
  38. CALCIUM-HYPERCALCEMIA MANAGEMENT‏‎ (11:07, 20 March 2023)
  39. DIABETES MELLITUS-ALPHA-GLUCOSIDASE INHIBITORS‏‎ (11:07, 20 March 2023)
  40. PITUITARY-APOPLEXY‏‎ (11:07, 20 March 2023)
  41. HYPERPARATHYROIDISM-SUMMARY‏‎ (11:07, 20 March 2023)
  42. OSTEOPOROSIS-VITAMIN D SYNTHESIS‏‎ (11:07, 20 March 2023)
  43. OSTEOPOROSIS-INX, BLOODS OR URINE‏‎ (11:07, 20 March 2023)
  44. HYPERTHYROIDISM-TOXIC ADENOMA‏‎ (11:07, 20 March 2023)
  45. MYXEDEMA COMA-INVESTIGATIONS‏‎ (11:07, 20 March 2023)
  46. DIABETES MELLITUS-SECRETAGOGUES‏‎ (11:07, 20 March 2023)
  47. PHAEOCHROMOCYTOMA-IMAGING‏‎ (11:07, 20 March 2023)
  48. OSTEOPOROSIS-MANAGEMENT (TERIPARATIDE)‏‎ (11:07, 20 March 2023)
  49. DIABETES MELLITUS-ANTIPLATELET THERAPY‏‎ (11:07, 20 March 2023)
  50. PITUITARY-EMPTY SELLA‏‎ (11:07, 20 March 2023)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)